Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.
暂无分享,去创建一个
E. Jönsson | M. Landén | S. Erhardt | M. Samuelsson | L. Lindström | P. Saetre | G. Engberg | C. Nordin | S. Olsson
[1] S. Rossell,et al. Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. , 2009, The international journal of neuropsychopharmacology.
[2] M. Thase,et al. A history of childhood attention‐deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD , 2009, Acta psychiatrica Scandinavica.
[3] K. Larsson,et al. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia. , 2009, The international journal of neuropsychopharmacology.
[4] Tyrone D. Cannon,et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.
[5] S. Erhardt,et al. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area. , 2008, Life sciences.
[6] S. Erhardt,et al. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis , 2007, Neuropharmacology.
[7] M. Bourin,et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder , 2007, Acta psychiatrica Scandinavica. Supplementum.
[8] D. Bucci,et al. Elevations of endogenous kynurenic acid produce spatial working memory deficits. , 2007, Schizophrenia bulletin.
[9] M. Gisslén,et al. Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid , 2007, Brain, Behavior, and Immunity.
[10] W. Turski,et al. Enhancement of brain kynurenic acid production by anticonvulsants--novel mechanism of antiepileptic activity? , 2006, European journal of pharmacology.
[11] D. Bucci,et al. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding , 2006, Behavioural Brain Research.
[12] S. Erhardt,et al. Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons , 2006, Journal of Neural Transmission.
[13] S. Erhardt,et al. Effects of COX‐1 and COX‐2 inhibitors on the firing of rat midbrain dopaminergic neurons—Possible involvement of endogenous kynurenic acid , 2006, Synapse.
[14] Sheri L. Johnson,et al. The psychopathology and treatment of bipolar disorder. , 2006, Annual review of clinical psychology.
[15] T. Robbins,et al. Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition , 2006, Trends in pharmacological sciences.
[16] F. Joseph McClernon,et al. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization , 2006, Psychopharmacology.
[17] S. Weis,et al. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder , 2006, Brain Research.
[18] R. Schwarcz,et al. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain , 2006, Journal of Neural Transmission.
[19] K. Blennow,et al. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia , 2005, Schizophrenia Research.
[20] M. Geyer,et al. Endogenous kynurenic acid disrupts prepulse inhibition , 2004, Biological Psychiatry.
[21] Eduard Vieta,et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. , 2004, The American journal of psychiatry.
[22] D. Kupfer,et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) , 2003, Biological Psychiatry.
[23] S. Erhardt,et al. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid. , 2002, Acta physiologica Scandinavica.
[24] Luke Clark,et al. Sustained attention deficit in bipolar disorder. , 2002, The British journal of psychiatry : the journal of mental science.
[25] D. Blackwood,et al. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. , 2002, The British journal of psychiatry : the journal of mental science.
[26] K. Blennow,et al. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia , 2001, Neuroscience Letters.
[27] R. Schwarcz,et al. Increased cortical kynurenate content in schizophrenia , 2001, Biological Psychiatry.
[28] R. Schwarcz,et al. The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications , 2001, The Journal of Neuroscience.
[29] William Perry,et al. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania , 2001, Biological Psychiatry.
[30] Tyrone D. Cannon,et al. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. , 2001, Bipolar disorders.
[31] C. Parsons,et al. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. , 1997, The Journal of pharmacology and experimental therapeutics.
[32] R. Schwarcz,et al. Brain‐Specific Modulation of Kynurenic Acid Synthesis in the Rat , 1997, Journal of neurochemistry.
[33] M. Demitrack,et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. , 1992, Brain : a journal of neurology.
[34] R. Schwarcz,et al. Age-related changes in kynurenic acid production in rat brain , 1992, Brain Research.
[35] M. Beal,et al. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] M. Beal,et al. Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. , 1990, Analytical biochemistry.
[37] G. Lombardi,et al. Kynurenic acid is present in the rat brain and its content increases during development and aging processes , 1988, Neuroscience Letters.
[38] C. Grossman,et al. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. , 1988, European journal of pharmacology.
[39] S. Erhardt,et al. Pharmacological Manipulation of Kynurenic Acid , 2009, CNS drugs.
[40] E. Jönsson,et al. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors. , 2007, Journal of psychiatric research.
[41] R. Schwarcz,et al. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] S. Erhardt,et al. Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons , 2001, Amino Acids.
[43] L. Altshuler,et al. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. , 1998, Archives of general psychiatry.
[44] M. First,et al. Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .
[45] M. Geyer,et al. Startle habituation and sensorimotor gating in schizophrenia and related animal models. , 1987, Schizophrenia bulletin.